Publications by authors named "Shervin Assassi"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

254

Total Likes

0

Extended Reach

3,660

Social Features

4
E
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression.
Dinesh Khanna, Toby M Maher, Elizabeth R Volkmann, Yannick Allanore, Vanessa Smith, Shervin Assassi, Michael Kreuter, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Christian Stock

RMD Open· February 2023

Videos about Article: user

1 3 3

View All Article and Social Media Activity
F
FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease.
Elana J Bernstein, Francesco Boin, Brett Elicker, Yiming Luo, Yawen Ren, Shervin Assassi

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualizing NSAID therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis.
Mark C Hwang, Seokhun Kim, Shervin Assassi, Reyna Chavez, Joyce Samuel

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK5 inhibitor impact on bleomycin-induced systemic sclerosis mouse model via multifunctional optical coherence tomography.
Pavel V Nikitin, Harshdeep S Chawla, Jessica Gutierrez, Geethangili Madamanchi, Manmohan Singh, Shervin Assassi

APL Bioeng· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON).
Wim A Wuyts, Luca Richeldi, Shervin Assassi, Arata Azuma, Vincent Cottin

BMC Pulm Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early gastrointestinal manifestations predict outcomes in patients with systemic sclerosis.
Ali Y Ayla, Ashish P Balar, Ernesto Calderon Martinez, Bingrui Chen, Claudia Pedroza, Shervin Assassi

medRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts.
Iqtidar Hanif, Shervin Assassi, Maureen D Mayes, Zsuzsanna H McMahan, Meng Zhang

Arthritis Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypes.
Javier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Alfredo Guillen-Del-Castillo, Carmen P Simeón-Aznar, Shervin Assassi

Arthritis Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Ali Y Ayla, Elana J Bernstein, Meng Zhang, John M VanBuren, Flavia V Castelino, Shervin Assassi

J Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for the treatment of systemic sclerosis.
Jörg H W Distler, Masataka Kuwana, Shervin Assassi, Christopher P Denton

Nat Rev Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of skin in patients with systemic sclerosis using high-frequency ultrasound and shear wave elastography: A comparative study with histology, molecular and clinical parameters.
Ruhani Desai, Filemon Tan, Minghua Wu, Jeffery L Browning, Samuel Theodore, Shervin Assassi

Arthritis Care Res (Hoboken)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies.
Elizabeth R Volkmann, Shervin Assassi, Christopher P Denton, Rozeta Simonovska, Steven Sambevski

J Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.
Yiming Luo, Shervin Assassi, Maureen D Mayes, Tracy M Frech, Virginia D Steen

Ann Am Thorac Soc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative exome sequencing and machine learning identify MICB and interferon pathway genes as contributors to SSc risk.
Shamika Ketkar, Hongzheng Dai, Lindsay Burrage, David Murdock, Brian Dawson, Shervin Assassi

Ann Rheum Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease.
Carlos Rosa-Baez, Carlos Rangel-Pelaez, Inmaculada Rodriguez-Martin, Martin Kerick, Alfredo Guillen-Del-Castillo, Shervin Assassi

RMD Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Sclerosis: A Multisystem Disease; Time to Think Beyond Scleroderma.
Yannick Allanore, Shervin Assassi

Arthritis Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Elizabeth R Volkmann, Holly Wilhalme, Donald P Tashkin, Grace Hyun J Kim, Jonathan Goldin, Shervin Assassi

Arthritis Care Res (Hoboken)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study.
Monique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, Stefano Di Donato, Antonio Carriero, Shervin Assassi

Lancet Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nerandomilast in Patients with Progressive Pulmonary Fibrosis.
Toby M Maher, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold

N Engl J Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis.
Shervin Assassi, Christopher P Denton, Matthias Zwick, Ramona Schmid, Carina Ittrich

Arthritis Rheumatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis.
Jeong Min Yu, John M VanBuren, Angela Child, Jessica S Alvey, Lisa A Mandl, Shervin Assassi

J Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of skin fibrosis in a murine model of systemic sclerosis with multifunctional optical coherence tomography.
Harshdeep Singh Chawla, Yanping Chen, Minghua Wu, Pavel Nikitin, Jessica Gutierrez, Shervin Assassi

J Biomed Opt· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1 monocytes-derived macrophages.
Xinran Yuan, Xiaodong Qin, Kenji Takemoto, Jian Zhao, Matthew Sanderson, Shervin Assassi

Ann Rheum Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association of the PLD4 SNP rs2841277 with systemic sclerosis in a European American population.
Yunqing Ma, Maureen D Mayes, Xinjian Guo, Shervin Assassi, Xiaodong Zhou

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing statistical challenges in the analysis of proteomics data with extremely small sample size: a simulation study.
Kyung Hyun Lee, Shervin Assassi, Chandra Mohan, Claudia Pedroza

BMC Genomics· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease.
Dinesh Khanna, Luke B Evnin, Shervin Assassi, Wade W Benton, Gregory Gordon

J Scleroderma Relat Disord· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis